Phase 2 study of sunitinib in refractory thyroid cancer.
Cohen EE, Needles BM, Cullen KJ, Wong SJ, Wade Iii JL, Ivy SP, Villaflor VM, Seiwert TY, Nichols K, Vokes EE. Phase 2 study of sunitinib in refractory thyroid cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6025.